|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02500 VENUS MEDTECH-B
Nominal 
3.840 -0.100 (-2.538%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 187,137 | -18.890% | 230,720 | 255,610 | 209,965 | 239,269 |
| Cost of Sales | (49,149) | 0.386% | (48,960) | (54,361) | (45,790) | (51,181) |
| Gross Profit | 137,988 | -24.082% | 181,760 | 201,249 | 164,175 | 188,088 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 1,238 | 62.042% | 764 | (9,656) | (3,595) | (3,195) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (2,265) | 253.354% | (641) | (6,964) | (14,593) | (6,523) | |
| Profit / (Loss) before Taxation | (138,564) | -35.123% | (213,581) | (370,339) | (246,406) | (117,211) | |
| Taxation | 3,792 | -20.269% | 4,756 | 4,124 | 6,738 | (4) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 2,338 | 16,027 | 39,735 | 4,152 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (134,772) | -34.731% | (206,487) | (350,188) | (199,933) | (113,063) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 7,172 | -26.854% | 9,805 | 31,185 | 18,400 | 984 |
| Depreciation & Amortisation | 49,368 | -15.596% | 58,490 | 56,056 | -- | -- |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | -31.000 | -34.043% | -47.000 | -80.000 | -46.000 | -26.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 4.685 | -- | 6.180 | 7.511 | 10.023 | 11.077 |
| Remarks: | Real time quote last updated: 12/09/2025 17:21 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -134,772 |
| %Change | -34.731% |
| EPS / (LPS) | RMB -0.310 |
| NBV Per Share (¥) | RMB 4.685 |